Type 1 diabetes and cardiovascular disease

Real-world study data show that non-fasting remnant cholesterol levels are associated with a significantly increased risk for CVD in people without diabetes, with a similar, but nonsignificant, trend observed in those with diabetes.

The presence of chronic kidney disease has a large impact on the likelihood of people with type 1 diabetes dying after a myocardial infarction, show findings from the FinnDiane Study.

The strength of the association between diabetes and the risk for cardiovascular events has lessened over recent years, report researchers.

Hepatic steatosis, measured by the fatty liver index, is associated with an increased risk for mortality and cardiovascular disease among people with type 1 diabetes, research suggests.

The risk for receiving a new diabetes diagnosis is increased “for at least 12 weeks” after COVID-19 illness, but then declines, say researchers.

Results from a nationwide registry study show that having type 1 diabetes places people at a significantly increased risk for dying within a year after having a myocardial infarction.

A randomized crossover trial shows that both hypoglycemia and rebound hyperglycemia trigger persistent increases in left ventricular function in people with type 1 diabetes.

Having blood pressure that is higher at night than during the day is associated with an increased mortality risk in people with diabetes, shows a 21-year study.

The presence of diabetes in people with preclinical heart failure shortens the time to a first clinical event, especially if blood glucose is poorly controlled, show data from the ARIC study.

Moderate- or high-intensity rosuvastatin and high-intensity simvastatin and atorvastatin are the most effective statins for reducing non-high-density lipoprotein cholesterol levels in people with diabetes, study findings indicate.

People with diabetes and atrial fibrillation have a lower risk for vascular complications if they are given non-vitamin K antagonist oral anticoagulants rather than warfarin, show results of a population-based study.

Having first-degree relatives with type 2 diabetes may be associated with an increased risk for cardiovascular disease and microvascular complications among people with type 1 diabetes, particularly those diagnosed at a young age, study findings suggest.

Higher BMI, waist circumference, and fat mass are each significantly associated with an increased risk for heart failure among older people with diabetes but not among those without diabetes, US researchers report.

Risk factors for cardiovascular disease may vary by longitudinal glycated hemoglobin trajectory in people with type 1 diabetes, US researchers report.

The presence of cardiac abnormalities in people with diabetes forewarns of an increased risk for incident heart failure over the next few years, say researchers

The optimal glycemic targets in people with diabetes who have had a stroke may vary according to the stroke subtype, a registry study suggests.

People with type 1 diabetes have a greater risk for incident cardiovascular and renal disease than those with type 2 diabetes, suggest findings from a French nationwide observational study presented at the virtual 57th EASD Annual Meeting.

Researchers have identified an association between insulin resistance and arterial stiffness among people with type 1 diabetes.

People with type 1 diabetes who do not experience a nocturnal reduction in blood pressure may have an elevated risk for mortality and adverse kidney events, research suggests.

Findings from the Hypo-RESOLVE study suggest that exposure to hypoglycemia is associated with subsequent negative clinical outcomes in people with diabetes, supporting a key role for hypoglycemia prevention.